X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-15 | WVE | Bolno Paul | Pres, CEO | S - Sale | $14.32 | -51,234 | 217,351 | -19% | -$733,671 | ||||||
D | 2024-11-08 | WVE | Francis Chris | See Remarks | S - Sale+OE | $16.00 | -36,000 | 0 | -100% | -$576,000 | |||||
D | 2024-10-16 | WVE | Francis Chris | See Remarks | S - Sale+OE | $13.67 | -208,836 | 0 | -100% | -$2,855,051 | |||||
2024-10-16 | WVE | Bolno Paul | Pres, CEO | S - Sale | $15.00 | -90,474 | 268,585 | -25% | -$1,357,110 | ||||||
2024-09-27 | WVE | Gsk Plc | 10% | P - Purchase | $8.00 | +2,791,930 | 16,775,691 | +20% | +$22,335,440 | ||||||
2024-09-25 | WVE | Moran Kyle | CFO | S - Sale | $9.00 | -17,146 | 19,777 | -46% | -$154,314 | ||||||
2024-08-21 | WVE | Bolno Paul | Pres, CEO | S - Sale | $5.78 | -48,366 | 359,059 | -12% | -$279,555 | ||||||
2024-04-03 | WVE | Moran Kyle | CFO | S - Sale | $6.17 | -15,630 | 33,921 | -32% | -$96,421 | ||||||
2023-12-07 | WVE | Gsk Plc | 10% | P - Purchase | $5.00 | +3,300,000 | 13,983,761 | +31% | +$16,500,000 | ||||||
A | 2023-12-11 | WVE | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $5.00 | +1,000,000 | 18,202,009 | +6% | +$5,000,000 | |||||
2023-12-11 | WVE | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $5.00 | +1,000,000 | 19,202,009 | +5% | +$5,000,000 | ||||||
2023-08-23 | WVE | Moran Kyle | CFO | S - Sale | $4.75 | -37,062 | 46,120 | -45% | -$176,119 | ||||||
D | 2023-02-16 | WVE | Vargeese Chandra | See Remarks | S - Sale+OE | $4.03 | -10,249 | 106,624 | -9% | -$41,303 | |||||
D | 2023-02-16 | WVE | Bolno Paul | Pres, CEO | S - Sale+OE | $4.04 | -29,400 | 407,425 | -7% | -$118,776 | |||||
D | 2023-02-16 | WVE | Francis Chris | See Remarks | S - Sale+OE | $4.03 | -10,258 | 79,714 | -11% | -$41,340 | |||||
D | 2023-02-16 | WVE | Moran Kyle | CFO | S - Sale+OE | $4.04 | -9,729 | 79,751 | -11% | -$39,305 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |